Johnson & Johnson vs JPMorgan Chase: Founders, CEOs and History
Johnson & Johnson was founded in 1886 by Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson and is led by Joaquin Duato. JPMorgan Chase was founded in 1799 by Aaron Burr, Alexander Hamilton, John Pierpont Morgan and is led by Jamie Dimon.
Company facts
Johnson & Johnson
- Founded
- 1886
- Headquarters
- New Brunswick, New Jersey
- Current CEO
- Joaquin Duato
- Employees
- 140,800
JPMorgan Chase
- Founded
- 1799
- Headquarters
- New York, New York
- Current CEO
- Jamie Dimon
- Employees
- 318,512
Founders
Johnson & Johnson
Robert Wood Johnson
Robert Wood Johnson (1845-1910) co-founded Johnson & Johnson in 1886 and served as its first president.
James Wood Johnson
James Wood Johnson (1856-1932) co-founded J&J with his brothers in 1886. An engineer by trade, he designed the early manufacturing machinery that allowed the company to mass-produce sterile surgical dressings.
Edward Mead Johnson
Edward Mead Johnson (1852-1934) co-founded J&J in 1886, bringing crucial sales and marketing expertise to the early business.
JPMorgan Chase
Aaron Burr
Aaron Burr, the New York lawyer and politician who later served as U.S. vice president, led the 1799 effort to charter the Manhattan Company.
Alexander Hamilton
Alexander Hamilton, the first U.S. Treasury Secretary, is linked to JPMorgan Chase's history through his involvement in the 1799 Manhattan Company charter effort alongside Aaron Burr.
John Pierpont Morgan
J. Pierpont Morgan co-founded Drexel, Morgan & Co. with Anthony Drexel in 1871, the partnership that became J.P. Morgan & Co. in 1895. The firm financed railroads and organized industrial combinations such as U.S. Steel in 1901.
CEOs and their tenures
Johnson & Johnson
- Ralph Larsen1989–2002
Former Chairman and Chief Executive Officer
Larsen's acquisitions, including Neutrogena, Cordis, DePuy, and Centocor, broadened J&J into medical devices and biologics, laying groundwork for today's MedTech segment and immunology franchise.
Source - William Weldon2002–2012
Former Chairman and Chief Executive Officer
Weldon's later years were overshadowed by a wave of consumer product recalls, including Tylenol and Motrin, tied to manufacturing-quality problems.
Source - Alex Gorsky2012–2022
Former Chairman and Chief Executive Officer
Gorsky's tenure set up the 2023 Kenvue separation completed under his successor and saw J&J's single-dose COVID-19 vaccine authorized in 2021. He also oversaw the $30 billion Actelion acquisition in 2017 and the early years of talc litigation.
Source - Joaquin Duato2022–present
Chairman and Chief Executive Officer
Under Duato, J&J's sales reached $94.193 billion in FY2025 with $26.804 billion in net earnings, and the company guides to its first $100 billion year in 2026. He also launched the DePuy Synthes separation and the 2026 talc settlement proposal.
Source
JPMorgan Chase
- William B. Harrison Jr.2000–2005
Former Chairman and Chief Executive Officer
Harrison's tenure connects the creation of modern JPMorgan Chase with the leadership structure that followed. He oversaw the first stage of integrating Chase and Morgan, then added Bank One's consumer and middle-market operations.
Source - Jamie Dimon2006–present
Chairman and Chief Executive Officer
Dimon's tenure established the operating and risk framework associated with JPMorgan Chase's scale. The company combines Consumer & Community Banking, Commercial & Investment Bank, and Asset & Wealth Management rather than relying on one earnings engine.
Source - Jeremy Barnum2021–present
Chief Financial Officer
He oversees capital, liquidity and financial reporting for a $4.9 trillion balance sheet.
Source - Doug Petno2026–present
Co-President and CEO, Commercial & Investment Bank
He oversees JPMorgan's largest segment by managed revenue, which produced $78.5 billion in FY2025.
Source - Troy Rohrbaugh2026–present
Co-President and CEO, Consumer & Community Banking
He now runs the Chase consumer franchise, which produced $76.0 billion of FY2025 managed revenue.
Source
Timeline: Johnson & Johnson and JPMorgan Chase side by side
1799JPMorgan Chase
Manhattan Company Chartered
Aaron Burr and Alexander Hamilton led the effort to obtain a New York charter for the Manhattan Company.
1871JPMorgan Chase
Drexel, Morgan & Co. Formed
J. Pierpont Morgan and Anthony Drexel formed Drexel, Morgan & Co. in New York. The partnership developed into J.P. Morgan & Co., creating the Morgan banking lineage that would remain separate from Chase until the companies combined in 2000.
1886Johnson & Johnson
Johnson & Johnson Founded
Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson found the company in New Brunswick, New Jersey, with 14 employees, to mass-produce sterile surgical dressings after Robert was inspired by antiseptic pioneer Joseph Lister's 1885 warnings about i…
1907JPMorgan Chase
Panic of 1907
During the Panic of 1907, J. Pierpont Morgan organized bankers and other private participants to support strained financial institutions. The episode became a defining part of the Morgan firm's history in an era before the Federal Reserve existed.
1920Johnson & Johnson
Band-Aid Brand Adhesive Bandages Introduced
J&J introduces the first mass-produced adhesive bandage, sold under the Band-Aid brand starting in 1921; it becomes one of the most recognized consumer-health brands in the world before J&J later spins its consumer division out as Kenvue in 2023.
1943Johnson & Johnson
Robert Wood Johnson II Writes 'Our Credo'
Chairman Robert Wood Johnson II authors 'Our Credo,' a one-page statement ranking the company's responsibilities to customers, employees, communities, and shareholders in that order; it remains J&J's official governing philosophy and was later cited as the bas…
1944Johnson & Johnson
J&J Goes Public
Johnson & Johnson lists publicly, becoming an independent, market-traded company as it expands into a diversified healthcare business under Chairman Robert Wood Johnson II.
1955JPMorgan Chase
Chase Manhattan Created
The Bank of the Manhattan Company merged with Chase National Bank to form Chase Manhattan Bank. This combination joined the firm's oldest 1799 predecessor with the Chase name and created the institution that later merged with J.P. Morgan.
1982Johnson & Johnson
Tylenol Cyanide Poisonings and Nationwide Recall
After seven people in the Chicago area die from cyanide-laced Extra-Strength Tylenol capsules, J&J issues a nationwide recall of 31 million bottles within a week -- far beyond what investigators said was necessary -- citing Our Credo's customer-safety priority…
2000JPMorgan Chase
Chase and J.P. Morgan Merge
Chase Manhattan and J.P. Morgan & Co. completed their merger, combining commercial and consumer banking with investment banking and institutional services. JPMorgan Chase identifies this transaction as the formation of the modern company.
2004JPMorgan Chase
Bank One Merger
JPMorgan Chase completed its $58.546 billion stock-for-stock merger with Bank One on July 1.
2006JPMorgan Chase
Jamie Dimon Becomes CEO
Jamie Dimon succeeded William B. Harrison Jr. as chief executive on January 1. Dimon had joined JPMorgan Chase as president and chief operating officer when the Bank One merger closed and became chairman one year after becoming CEO.
2008JPMorgan Chase
Bear Stearns Acquired
JPMorgan Chase completed its acquisition of Bear Stearns during the financial crisis.
2008JPMorgan Chase
Washington Mutual Operations Acquired
After Washington Mutual Bank entered FDIC receivership, JPMorgan Chase paid $1.9 billion to acquire its banking operations, including assets, deposits, and qualified financial contracts under the transaction terms.
2012Johnson & Johnson
Alex Gorsky Becomes CEO
Gorsky succeeds William Weldon as CEO amid a period of manufacturing-quality recalls, and spends the next decade restoring J&J's operational reputation while expanding the pharmaceutical and MedTech businesses and developing a single-dose COVID-19 vaccine duri…
2022Johnson & Johnson
Joaquin Duato Becomes CEO
Duato becomes CEO in January 2022, later adding the chairman title, and begins preparing the separation of J&J's consumer-health business from its medicine and device operations.
2023Johnson & Johnson
Kenvue Separation
J&J completes the spinoff of its consumer-health business (Band-Aid, Tylenol, Listerine, Neutrogena) as the standalone public company Kenvue, narrowing J&J around its higher-margin Innovative Medicine and MedTech segments.
2023JPMorgan Chase
First Republic Acquired from FDIC
JPMorgan Chase acquired the substantial majority of First Republic Bank's assets and assumed deposits and certain liabilities from the FDIC.
2025Johnson & Johnson
FY2025 Sales of $94.193B
Johnson & Johnson reports $94.193 billion in sales and $26.804 billion in net earnings, split roughly 64% Innovative Medicine and 36% MedTech, both segments growing about 6% year over year.
2025Johnson & Johnson
Orthopaedics Separation Announced
In October 2025 J&J announced plans to separate its orthopaedics business as a standalone company operating as DePuy Synthes, targeting completion in 2027.
2025JPMorgan Chase
FY2025 Net Revenue of $182.447B
JPMorgan Chase reported U.S. GAAP total net revenue of $182.447 billion and net income of $57.048 billion. Its managed, fully taxable-equivalent segment presentation reported $185.581 billion of total net revenue across CCB, CIB, AWM, and Corporate.
2026Johnson & Johnson
Proposed Talc Resolution and Raised Guidance
J&J raised 2026 sales guidance to about $101.1 billion after Q2 sales of $25.31 billion, and on July 27, 2026 proposed an estimated $5.5 billion resolution of remaining ovarian talc claims.
2026JPMorgan Chase
Chase to Become Apple Card Issuer
On January 7, 2026 Apple and Chase announced that Chase will replace Goldman Sachs as Apple Card issuer over about 24 months.
2026JPMorgan Chase
Co-Presidents Named
Doug Petno and Troy Rohrbaugh were named co-presidents in June 2026, and Marianne Lake announced her retirement.
Acquisitions
Johnson & Johnson
- Intra-Cellular Therapies2025$14.6B
- Shockwave Medical2024$13.1B
- Kenvue separation2023Undisclosed
- Abiomed2022$16.6B
- Actelion2017$30B
JPMorgan Chase
- First Republic Bank2023$10.6B
- The Bear Stearns Companies Inc.2008$1.5B
- Washington Mutual banking operations2008$1.9B
- Bank One Corporation2004$58.5B
- J.P. Morgan & Co.2000Undisclosed
Questions about Johnson & Johnson vs JPMorgan Chase
Who is the CEO of Johnson & Johnson and JPMorgan Chase & Co.?
Johnson & Johnson is led by Joaquin Duato and JPMorgan Chase & Co. is led by Jamie Dimon. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Johnson & Johnson founded vs JPMorgan Chase & Co.?
JPMorgan Chase & Co. was founded in 1799 — 87 years before Johnson & Johnson, which was founded in 1886. JPMorgan Chase & Co.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Johnson & Johnson.
How many employees does Johnson & Johnson have compared to JPMorgan Chase & Co.?
Johnson & Johnson employs approximately 140,800 people, while JPMorgan Chase & Co. employs approximately 318,512. JPMorgan Chase & Co. has the larger workforce at 318,512 employees, compared to Johnson & Johnson's 140,800. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Johnson & Johnson and JPMorgan Chase & Co. headquartered?
Both Johnson & Johnson and JPMorgan Chase & Co. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded Johnson & Johnson and JPMorgan Chase & Co.?
Johnson & Johnson was founded by Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson. JPMorgan Chase & Co. was founded by Aaron Burr, Alexander Hamilton, John Pierpont Morgan.
Which company has a longer operating history — Johnson & Johnson or JPMorgan Chase & Co.?
JPMorgan Chase & Co. has been operating for approximately 227 years, making it the more established of the two companies. Johnson & Johnson has been in operation for around 140 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Johnson & Johnson vs JPMorgan Chase overview